![LIPO-C [FAT BLASTER]](https://lightningpeptidesllc.com/wp-content/uploads/2026/09/ChatGPT-Image-Sep-8-2026-06_58_33-PM.webp)
Fat Blaster Research Blend
Methionine + Inositol + Choline + L-Carnitine + Vitamin B12
A multi-component lipotropic research formulation developed for studies involving lipid metabolism, fatty-acid transport, cellular energy production, and methylation pathways. L-Carnitine is involved in transporting fatty acids into mitochondria, while methionine, inositol, choline, and B12 participate in various metabolic processes—making this a compelling “Fat Blaster” metabolic research blend.
For research purposes only.
Fat Blaster Research Blend
Methionine + Inositol + Choline + L-Carnitine + Vitamin B12
A multi-component lipotropic research formulation developed for studies involving lipid metabolism, fatty-acid transport, cellular energy production, and methylation pathways. L-Carnitine is involved in transporting fatty acids into mitochondria, while methionine, inositol, choline, and B12 participate in various metabolic processes—making this a compelling “Fat Blaster” metabolic research blend.
For research purposes only.
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥99% |
| Form | Lyophilized powder |
-20°C · 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | GLP3-RT 10mg |
|---|---|
| Lot # | REF0001 |
| Labeled | 20mg |
| Actual | 22.61mg |
| Tested | APR 15, 2026 |
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
on orders over $200
plain and unbranded packaging
256-bit SSL
Not a researcher? Exit
